Table of Contents
| Sequential maximum androgen blockade (MAB) in minimally symptomatic prostate cancer progressing after initial MAB: two case reports | PDF HTML |
| Mohan Hingorani, Sanjay Dixit, Fahim Bashir, Mohammad Butt, Simon Hawkyard, Richard Khafagy, Andrew Robertson | 277-280 |
| Report on the 9th International Congress on Peritoneal Surface Malignancies | PDF HTML |
| Yan Li, Yang Yu, Yang Liu | 281-284 |
Review
| Minimally invasive local therapies for liver cancer | PDF HTML |
| David Li, Josephine Kang, Benjamin J. Golas, Vincent W. Yeung, David C. Madoff | 217-236 |
| Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma | PDF HTML |
| Teresa Kim, Rodabe N. Amaria, Christine Spencer, Alexandre Reuben, Zachary A. Cooper, Jennifer A. Wargo | 237-246 |
| Recent advances in lymphatic targeted drug delivery system for tumor metastasis | PDF HTML |
| Xiao-Yu Zhang, Wei-Yue Lu | 247-254 |
| Emerging function of mTORC2 as a core regulator in glioblastoma: metabolic reprogramming and drug resistance | PDF HTML |
| Si-Han Wu, Jun-Feng Bi, Timothy Cloughesy, Webster K. Cavenee, Paul S. Mischel | 255-263 |
Original Article
| Argyrophilic nucleolar organizer region in MIB-1 positive cells in non-small cell lung cancer: clinicopathological significance and survival | PDF HTML |
| Dmitriy Sergeevich Kobyakov, Ashot Merudzhanovich Avdalyan, Aleksandr Fedorovich Lazarev, Elena Leonidovna Lushnikova, Lev Moiseevich Nepomnyashchikh | 264-269 |
| Effect of EGFR-TKI retreatment following chemotherapy for advanced non-small cell lung cancer patients who underwent EGFR-TKI | PDF HTML |
| Guo-Hao Xia, Yun Zeng, Ying Fang, Shao-Rong Yu, Li Wang, Mei-Qi Shi, Wei-Li Sun, Xin-En Huang, Jia Chen, Ji-Feng Feng | 270-276 |
OUR FRIENDS
